Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Sacral agenesis, also known as caudal regression syndrome, was first systematically described in the mid-20th century as a spectrum of developmental anomalies affecting the lower spine and pelvis. Understanding of the condition has evolved from viewing it as a rare, isolated birth defect to recognizing it as a complex developmental field defect influenced by both maternal diabetes and potential genetic factors. When and how was Sacral agenesis / Caudal regression syndrome first described? While isolated cases of spinal anomalies were noted in early medical literature, the specific clinical entity now known as Sacral agenesis / Caudal regression syndrome was formally characterized in the 1960s.
TL;DR: Sacral agenesis, also known as caudal regression syndrome, was first systematically described in the mid-20th century as a spectrum of developmental anomalies affecting the lower spine and pelvis. Understanding of the condition has evolved from viewing it as a rare, isolated birth defect to recognizing it as a complex developmental field defect influenced by both maternal diabetes and potential genetic factors.
While isolated cases of spinal anomalies were noted in early medical literature, the specific clinical entity now known as Sacral agenesis / Caudal regression syndrome was formally characterized in the 1960s. In 1964, Dr. E.R. Duhamel coined the term "caudal regression syndrome" to describe the spectrum of malformations involving the sacrum, coccyx, and occasionally the lumbar spine. This classification was revolutionary because it moved medicine away from describing individual symptoms—such as absent vertebrae or lower limb hypoplasia—and toward understanding the condition as a cohesive disruption in embryonic development occurring between the 3rd and 7th weeks of gestation.
Historically, medical professionals struggled to identify a single cause for Sacral agenesis / Caudal regression syndrome. By the 1970s and 80s, clinical research identified a significant statistical correlation between the condition and maternal pre-gestational diabetes; infants of mothers with diabetes are approximately 200 to 400 times more likely to develop this syndrome than the general population. However, because many cases occur in the absence of maternal diabetes, researchers have increasingly looked toward environmental, vascular, and genetic triggers. Today, we understand that Sacral agenesis / Caudal regression syndrome is likely a multifactorial condition, where a disruption in the primitive streak during gastrulation leads to the characteristic fusion or absence of lower spinal segments.
The management of Sacral agenesis / Caudal regression syndrome has shifted from strictly palliative observation to a multidisciplinary approach focused on improving functional independence. Early history was marked by high mortality due to renal and pulmonary complications. Key milestones include:
In the past, individuals with Sacral agenesis / Caudal regression syndrome faced significant social stigma and limited resources. The rise of digital communities, including the 12 members currently sharing their experiences on DiseaseMaps.org, has been instrumental in shifting the narrative. Patient advocacy groups have successfully pushed for better transition-of-care programs, helping adolescents with the condition navigate the shift from pediatric to adult medical systems. This collective voice has fostered a focus on "neurodiversity" and functional outcomes rather than just anatomical correction.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.